Results 21 to 30 of about 3,460 (162)

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis [PDF]

Frontiers in Immunology, 2020
Background: TNF inhibitors (TNFis) are widely used for the treatment of rheumatoid arthritis (RA), although the response rates to this therapy in patients with RA remains heterogeneous and < 50% achieve remission (REM).Objective: To analyze baseline ...
Eulalia Rodríguez-Martín, Israel Nieto-Gañán, Borja Hernández-Breijo, Cristina Sobrino, Carlota García-Hoz, Javier Bachiller, Ana Martínez-Feito, Victoria Navarro-Compán, Paloma Lapuente-Suanzes, Gema Bonilla, Dora Pascual-Salcedo, Garbiñe Roy, Teresa Jurado, Pilar Nozal, Mónica Vázquez-Díaz, Alejandro Balsa, Luisa M. Villar, Chamaida Plasencia-Rodríguez   +17 more
doaj   +2 more sources

Long-term efficacy of cyclosporine and interferon-ω in feline chronic gingivostomatitis: insights from SDAI scores [PDF]

BMC Veterinary Research
Background Feline chronic gingivostomatitis (FCGS) is a challenging disease with unclear causes and limited treatment options. The most effective treatment for FCGS is tooth extraction.
Kue Hwan Choe, Kwangsik Jang, Se Eun Kim, Hyun Min Jo   +3 more
doaj   +2 more sources

Validación de un instrumento de ansiedad dental EQ-SDAI [PDF]

, 2019
Objective: The aim of this study was to validate an instrument of mass use to evaluate dental anxiety, by means of the dichotomization of a continuous variable of the Dental Anxiety Inventory short version instrument (SDAI) to a binary variable of ...
Jaramillo, Zoila, Castillo, Dayana, Villavicencio, Ebingen, Pariona, María del Carmen, Coronel, Paúl, Llapa, Maribel, Paúl Coronel, Maribel Llapa, María del Carmen Pariona, Ebingen Villavicencio, Zoila Jaramillo, Dayana Castillo   +11 more
core   +1 more source

The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study

Arthritis Research & Therapy, 2023
Background AVERT-2 (a phase IIIb, two-stage study) evaluated abatacept + methotrexate versus methotrexate alone, in methotrexate-naive, anti-citrullinated protein antibody-positive patients with early (≤ 6 months), active RA.
Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk, Clifton O. Bingham, Thomas W. J. Huizinga, Gustavo Citera, Kuan-Hsiang Gary Huang, Chun Wu, Sean E. Connolly, Yedid Elbez, Robert Wong, Karissa Lozenski, Roy Fleischmann   +12 more
doaj   +1 more source

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)

Научно-практическая ревматология, 2013
Objective: to estimate quality of life changes in patients with rheumatoid arthritis (RA) while adding tocilizumab (TCZ) to therapy with disease-modifying antirheumatic drugs (DMARDs) and to study the efficiency and safety of the therapy in RA patients ...
E Yu Panasyuk, V N Amirdzhanova, Anastasia Sergeyevna Avdeyeva, E L Luchikhina, E N Aleksandrova, A A Novikov, E L Nasonov   +6 more
doaj   +1 more source

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis

Научно-практическая ревматология, 2012
Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against ...
Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, G V Lukina, E L Nasonov   +4 more
doaj   +1 more source

Prevalencia de ansiedad y factores correlacionados en pacientes atendidos en clínica integral de odontología: Un estudio transversal [PDF]

Revista Científica Universidad Odontológica Dominicana
La ansiedad asociada con la atención odontológica es una preocupación común para muchas personas, manifestándose como una profunda inseguridad vinculada a las visitas y tratamientos dentales.
Luis Chauca Bajaña, Patricio Proaño Yela, José Albán Sánchez, Carla Juez Medina   +3 more
doaj   +1 more source

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS

Научно-практическая ревматология, 2012
Objective — to evaluate the impact of tocilizumab (TCZ) therapy on progression of joint destruction and rheumatoid arthritis (RA) inflammatory activity in 48 weeks after initiation of treatment. Material and methods.
Anastasia Sergeevna Avdeeva, A V Smirnov, E Yu Panasyuk, E N Alexandrova, E L Nasonov   +4 more
doaj   +1 more source

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)

Научно-практическая ревматология, 2014
Objective. To evaluate the effectiveness and tolerance of Etanercept (ETN) therapy in patients with rheumatoid arthritis (RA).Material and Methods. 188 adult patients with severe and moderate RA (average DAS28 score of 6.26±0.89) subcutaneously received ...
Anna Olegovna Pchelintseva, E Yu Panasyuk, O F Ryabitseva, V I Mazurov, I G Salikhov, A E Sizikov, O N Ivanova, V N Sorotskaya, O V Semagina, I V Vinogradova, A I Kulikov, L N Denisov, E L Nasonov   +12 more
doaj   +1 more source

Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression

Frontiers in Medicine, 2021
Objective: To compare the capacity of various disease activity indices to evaluate changes in function, IL-6 levels, and radiographic progression in early and established rheumatoid arthritis (RA).Methods: Secondary data analysis of a clinical trial ...
Sebastián C. Rodriguez-García, Nuria Montes, José Ivorra-Cortes, Ana Triguero-Martinez, Luis Rodriguez-Rodriguez, Isabel Castrejón, Loreto Carmona, Isidoro González-Álvaro   +7 more
doaj   +1 more source